 SALT LAKE CITY, Sept. 13, 2021 GLOBE NEWSWIRE -- Sera Prognostics Inc., The Pregnancy CompanyTM Nasdaq: SERA, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that the company will present at the Oppenheimer Fall Healthcare Life Sciences Med Tech Summit on Tuesday, September 21, 2021 at 8:15 a.m. Eastern Time. Gregory C. Critchfield, M.D., M.S., Chairman and CEO, will provide a company update and discuss Seras latest achievements. Seras management will also be available for one-on-one meetings with investors. 